Regeneron Pharmaceuticals Inc (REGN) — Analysis Summary
Regeneron Pharmaceuticals Inc (REGN) has a market cap of $64.45B with year-over-year revenue growth of +1.0%. Net margin stands at 31.4%. The stock trades at a P/E ratio of 14.6.
Key Takeaways
- Revenue changed +1.0% year-over-year
- Net margin of 31.4%
- P/E ratio of 14.6
Compared to other companies in the PHARMACEUTICAL PREPARATIONS sector, REGN posted revenue growth of +1.0% and trades at a P/E of 14.6.
Disclaimer: This is not financial advice. Data sourced from SEC EDGAR and Polygon.io. Past performance does not guarantee future results. Always conduct your own research before making investment decisions.